Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/04/1998 | EP0874842A1 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
11/04/1998 | EP0874841A1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor b2 antagonists |
11/04/1998 | EP0874840A1 Dibenzothiepin derivatives and pharmaceutical compositions |
11/04/1998 | EP0874839A1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
11/04/1998 | EP0874838A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
11/04/1998 | EP0874833A1 4,5-dihydronaphth 1,2-c]isoxazoles and derivatives thereof having cns activity |
11/04/1998 | EP0874830A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
11/04/1998 | EP0874829A1 Amino acid derivatives, the preparation and use thereof as endothelin antagonists |
11/04/1998 | EP0874828A1 Composition for treating pain |
11/04/1998 | EP0874827A1 Quinoline derivatives as nk3 antagonists |
11/04/1998 | EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
11/04/1998 | EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
11/04/1998 | EP0874822A1 New manufacturing process |
11/04/1998 | EP0874820A1 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine |
11/04/1998 | EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors |
11/04/1998 | EP0874818A1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
11/04/1998 | EP0874815A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
11/04/1998 | EP0874814A1 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols |
11/04/1998 | EP0874813A1 24-homo-26,27-hexafluoro-cholecalciferols |
11/04/1998 | EP0874812A1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
11/04/1998 | EP0874809A1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
11/04/1998 | EP0874808A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
11/04/1998 | EP0874805A1 Phenylacetamide derivatives |
11/04/1998 | EP0874800A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity |
11/04/1998 | EP0874665A1 Hollow-tube brachytherapy device |
11/04/1998 | EP0874643A2 Bioresponsive pharmacologically-active polymers and articles made therefrom |
11/04/1998 | EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
11/04/1998 | EP0874638A1 Hemoregulatory compounds |
11/04/1998 | EP0874637A1 Therapeutic applications of t-bam (cd40l) technology to treat inflammatory kidney diseases |
11/04/1998 | EP0874635A1 Non-immunogenic and toleragenic platelet and red blood cell compositions |
11/04/1998 | EP0874634A1 Control of healing process |
11/04/1998 | EP0874633A1 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial |
11/04/1998 | EP0874632A1 High-content famciclovir tablets |
11/04/1998 | EP0874631A1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
11/04/1998 | EP0874630A1 Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy |
11/04/1998 | EP0874629A1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS |
11/04/1998 | EP0874628A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy |
11/04/1998 | EP0874627A1 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors |
11/04/1998 | EP0874626A1 Use of inhibitors of retinoic acid activity for wound healing |
11/04/1998 | EP0874625A1 Indane derivatives for antipsychotic compositions |
11/04/1998 | EP0874624A2 Hyaluronic acid receptors binding agents and the use thereof |
11/04/1998 | EP0874623A2 Water activatable adhesive matrix containing amethocaine |
11/04/1998 | EP0874622A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
11/04/1998 | EP0874621A1 Pharmaceutical compositions |
11/04/1998 | EP0874619A1 Compositions for treating hair or skin |
11/04/1998 | EP0874558A1 Liquid oral compositions comprising a calcium compound and an acidulant |
11/04/1998 | EP0776328B1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
11/04/1998 | EP0714392B1 Heterocycles useful as neurokinin antagonists |
11/04/1998 | EP0710104B1 Pharmaceutical compositions for hardly soluble active substances |
11/04/1998 | EP0705244B1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
11/04/1998 | EP0696270B1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs |
11/04/1998 | EP0688167B1 Ionene polymers as microbicides |
11/04/1998 | EP0619802B1 A mixture of higher primary aliphatic alcohols and its pharmaceutical uses |
11/04/1998 | EP0552227B2 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
11/04/1998 | CN1198185A Detection, prevention and treatment of papillomatous digital dermatitis |
11/04/1998 | CN1198164A Novel water-soluble C-ring analogues of 20(s)-camptothecin |
11/04/1998 | CN1198162A Carbapenem antibiotic, composition and method of preparation |
11/04/1998 | CN1198161A Active oxygen scavengers containing pterin derivatives |
11/04/1998 | CN1198158A Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
11/04/1998 | CN1198097A Stable extract of hypericum perforatum L., process for preparing the same and pharmaceutical compositions |
11/04/1998 | CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen |
11/04/1998 | CN1198095A Antibacterial agents and cosmetics and clothes containing the same |
11/04/1998 | CN1198094A Solid medicaments obtained by extrusion of isomalt-containing polymer-active substance melt |
11/04/1998 | CN1198093A Hormone replacement therapy method and hormone dispenser |
11/04/1998 | CN1197799A Mesoplatinum complex and its synthesis |
11/04/1998 | CN1197797A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
11/04/1998 | CN1197650A Liver protecting and sobering preparation and its preparation process |
11/04/1998 | CN1197641A Medicine containing tan matter caesalpinia extract |
11/04/1998 | CN1197640A Ankang capsule for abstaining from drugs |
11/04/1998 | CN1197639A Rapamycin formulations for oral administration |
11/04/1998 | CN1197638A Amino acid derivatives and active oxygen-resistins agent |
11/04/1998 | CN1197637A Delayed Pyquiton and its preparation |
11/04/1998 | CN1197636A Freezing-dried tetracaine hydrochloride powder injection |
11/04/1998 | CN1040540C Anthracene ring antibiotic thioether conjugates, its prepn. and pharmaceutical composition containing same |
11/04/1998 | CN1040539C 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them |
11/04/1998 | CN1040537C Substituted 1,2,4-triazo (1,5-a) pyrimidines its prep. and pharmaceutical composition containing same |
11/04/1998 | CN1040505C Method for prep. of antihypertensive composition |
11/04/1998 | CN1040504C Process for preparation of pharmaceutical composition containing triazole derivative |
11/03/1998 | USRE35948 Pharmaceutical compositions |
11/03/1998 | US5831115 Inhibitors of squalene synthase and protein farnesyltransferase |
11/03/1998 | US5831094 Difluoro statone antiviral analogs |
11/03/1998 | US5831088 Osmylation |
11/03/1998 | US5831086 Crystal structure |
11/03/1998 | US5831072 Inhibitor of deaminase |
11/03/1998 | US5831068 Method to increase the density of antigen on antigen presenting cells |
11/03/1998 | US5831017 Divalent metal complex |
11/03/1998 | US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes |
11/03/1998 | US5830920 Prevention growth of smooth muscle cells |
11/03/1998 | US5830917 L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors |
11/03/1998 | US5830916 Inhibitor of ceramidase |
11/03/1998 | US5830915 Oral diseases; skin disorders; antiinflammatory agents |
11/03/1998 | US5830914 Apoptosis-controlling agent |
11/03/1998 | US5830913 Method for preventing or treating dry eye or disease caused therefrom |
11/03/1998 | US5830910 Alzheimer's disease |
11/03/1998 | US5830909 Dietetics |
11/03/1998 | US5830908 Crystalline hydrochloride of (R)-(-)-2-(N- 4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl-)-butyl!-aminomethyl)-chroman |
11/03/1998 | US5830907 Application of riluzole in the treatment of neurological lesions associated with trauma |
11/03/1998 | US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them |
11/03/1998 | US5830904 Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders |
11/03/1998 | US5830903 Triazole substituted quinoline derivatives for gastrointestinal treat-treatment |